1. Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid

   • Stefan R. Vink
   • Jan H. M. Schellens
   • Marcel Verheij

   OriginalPaper Pages: 279 - 286

2. Enhanced P53 and BAX gene expression and apoptosis in A549 cells by cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP

   • Beata Kosmider
   • Izabela Wojcik
   • Pawel Liberski

   OriginalPaper Pages: 287 - 297

3. A study of cytotoxic synergy of UCN-01 and flavopiridol in syngeneic pair of cell lines

   • Kongming Wu
   • Mark D’Amico
   • Sridhar Mani

   OriginalPaper Pages: 299 - 309

4. A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer

   • Kim N. Chi
   • Stephen K. Chia
   • Karen A. Gelmon

   OriginalPaper Pages: 311 - 315

5. Human metabolism of [¹⁴C]indisulam following i.v. infusion in cancer patients

   • Jan-Hendrik Beumer
   • Michel J. X. Hillebrand
   • Jos H. Beijnen

   OriginalPaper Pages: 317 - 330

6. Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer

   • Takahiko Sugiura
   • Yutaka Ariyoshi
   • Masahiro Fukuoka

   OriginalPaper Pages: 331 - 337

7. DE-310, a macromolecular prodrug of the topoisomerase-I-inhibitor exatecan (DX-8951), in patients with operable solid tumors

   • Moritz N. Wente
   • Jörg Kleeff
   • Helmut Friess

   OriginalPaper Pages: 339 - 347

8. Gemcitabine and mitoxantrone in metastatic breast cancer: A phase-I-study

   • Peter Schmid
   • Bernd Flath
   • Kurt Possinger

   OriginalPaper Pages: 349 - 356

9. Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme

   • Susan M. Chang
   • Patrick Wen
   • North American Brain Tumor Consortium and the National Cancer Institute

   OriginalPaper Pages: 357 - 361

10. BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: A phase II study group trial of the central European Society of Anticancer-Drug Research (CESAR)

    • R.-D. Hofheinz
    • C. Porta
    • A. Hochhaus

    OriginalPaper Pages: 363 - 368

11. Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study

    • Nicolas Tsavaris
    • Christos Kosmas
    • Efstathios Papalambros

    OriginalPaper Pages: 369 - 375

12. Phase I Study of Tomudex and Doxorubicin in Patients with Locally Advanced, Inoperable or Metastatic Cancer (IND.98)

    • Editorial Board

    Erratum Pages: 377 - 377

13. Pomegranate (Punica granatum) Pure Chemicals Show Possible Synergistic Inhibition of Human PC-3 Prostate Cancer Cell Invasion Across Matrigel^tm

    • Editorial Board

    Erratum Pages: 379 - 379